Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells
10.1023/a:1011884807746
Crossref journal-article
Springer Science and Business Media LLC
Clinical & Experimental Metastasis (297)
Bibliography

Voura, E. B., Chen, N., & Siu, C.-H. (2000). Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells. Clinical & Experimental Metastasis, 18(6), 527–532.

Authors 3
  1. Evelyn B. Voura (first)
  2. Ning Chen (additional)
  3. Chi-Hung Siu (additional)
References 34 Referenced 16
  1. Dejana E, Corada M Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J 1995; 9: 910–8. (10.1096/fasebj.9.10.7615160) / FASEB J by E Dejana (1995)
  2. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99: 3–8. (10.1172/JCI119129) / J Clin Invest by PJ. Newman (1997)
  3. Buckley CD, Doyonnas RI, Newton JP et al. Identification of α v β 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 1996; 109: 437–45. (10.1242/jcs.109.2.437) / J Cell Sci by CD Buckley (1996)
  4. Ayalon O, Sabanai H, Lampugnani MG et al. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 1994; 126: 247–58. (10.1083/jcb.126.1.247) / J Cell Biol by O Ayalon (1994)
  5. Sandig M, Voura EB, Kalnins VI et al. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskel 1997; 38: 351–64. (10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.0.CO;2-6) / Cell Motil Cytoskel by M Sandig (1997)
  6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301–14. (10.1016/0092-8674(94)90337-9) / Cell by TA. Springer (1994)
  7. Meier F, Stayamoorthy K, Nesbit M et al. Molecular events in melanoma development and progression. Frontiers Biosci 1998; 3: 1005–10. (10.2741/A341) / Frontiers Biosci by F Meier (1998)
  8. Orr FW, Wang HH, Lafrenie RM et al. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000; 190: 310–29. (10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P) / J Pathol by FW Orr (2000)
  9. Del Machio A, Zanetti A, Corada M et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 1996; 135: 497–510. (10.1083/jcb.135.2.497) / J Cell Biol by A Del Machio (1996)
  10. Allport JR, Muller WA, Luscinskas FW. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol 2000; 148: 206–16. (10.1083/jcb.148.1.203) / J Cell Biol by JR Allport (2000)
  11. Muller WA, Weigl SA, Deng X et al. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449–60. (10.1084/jem.178.2.449) / J Exp Med by WA Muller (1993)
  12. Bogen S, Pak J, Garifallou M et al. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994; 179: 1059–64. (10.1084/jem.179.3.1059) / J Exp Med by S Bogen (1994)
  13. Liao F, Huynh HK, Eiroa A et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 1995; 182: 1337–43. (10.1084/jem.182.5.1337) / J Exp Med by F Liao (1995)
  14. Liao F, Ali J, Greene T et al. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 1997; 185: 1349–57. (10.1084/jem.185.7.1349) / J Exp Med by F Liao (1997)
  15. Turegun M, Guedemex E, Newman P et al. Blockade of plateletendothelial cell adhesion molecule-1 (PECAM-1) protects against ischemia-reperfusion injury in muscle flaps at microcirculatory level. Plast Reconstr Surg 1999; 104: 1033–40. (10.1097/00006534-199909020-00021) / Plast Reconstr Surg by M Turegun (1999)
  16. Nakada MT, Amin K, Christofidou-Solomidou M et al. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol 2000; 164: 452–62. (10.4049/jimmunol.164.1.452) / J Immunol by MT Nakada (2000)
  17. Vaporciyan AA, DeLisser HM, Yan HC et al. Involvement of plateletendothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993; 262: 1580–2. (10.1126/science.8248808) / Science by AA Vaporciyan (1993)
  18. Bird IN, Taylor V, Newton JP et al. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J Cell Sci 1999; 112: 1989–97. (10.1242/jcs.112.12.1989) / J Cell Sci by IN Bird (1999)
  19. Voura EB, Sandig M, Kalnins VI et al. Cell shape changes and cytoskeleton reorganization during transendothelial migration of human melanoma cells. Cell Tissue Res 1998; 293: 375–87. (10.1007/s004410051129) / Cell Tissue Res by EB Voura (1998)
  20. Voura EB, Sandig M, Siu C-H. Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998; 43: 265–73. (10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z) / Microsc Res Tech by EB Voura (1998)
  21. Muller WA, Weigl SA. Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J Exp Med 1992; 176: 819–28. (10.1084/jem.176.3.819) / J Exp Med by WA Muller (1992)
  22. Takahashi K, Sawasaki Y, Hata JI et al. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 25: 265–74. (10.1007/BF02624456) / In Vitro Cell Dev Biol by K Takahashi (1990)
  23. Hughes S. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp Cell Res 1996; 225: 171–85. (10.1006/excr.1996.0168) / Exp Cell Res by S. Hughes (1996)
  24. Moreno JJ. Anitflammin-2 prevents HL-60 adhesion to endothelial cells and prostanoid production induced by lipopolysaccharides. J Pharmacol Exp Ther 2001; 296: 884–9. (10.1016/S0022-3565(24)38830-5) / J Pharmacol Exp Ther by JJ. Moreno (2001)
  25. Cheung WH, Lee KM Fung KP et al. Growth Plate chondrocytes inhibit neo-angiogenesis-a possible mechanism for tumor control. Cancer Lett 2001; 163: 25–32. (10.1016/S0304-3835(00)00653-4) / Cancer Lett by WH Cheung (2001)
  26. Brown J, Reading SJ, Jones S et al. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: A comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 2000; 80: 37–45. (10.1038/labinvest.3780006) / Lab Invest by J Brown (2000)
  27. Voura EB, Ramjeesingh RA, Montgomery AMP et al. Involvement of the integrin α v β 3 and the cell adhesion molecule L1 in the transendothelial migration of melanoma cells. Mol Biol Cell 2001; in press. (10.1091/mbc.12.9.2699)
  28. Rival Y, Del Maschio A, Rabiet MJ et al. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 1996; 157: 1233–41. (10.4049/jimmunol.157.3.1233) / J Immunol by Y Rival (1996)
  29. Sandig M, Negrou E, Rogers KA. Changes in the distribution of LFA-1, catenins, and F-actin during transendothelial migration of monocytes in culture. J Cell Sci 1997; 110: 2807–18. (10.1242/jcs.110.22.2807) / J Cell Sci by M Sandig (1997)
  30. Lewalle J-M, Bajou K, Desreux J et al. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interactions in vitro. Exp Cell Res 1997; 237: 347–56. (10.1006/excr.1997.3799) / Exp Cell Res by J-M Lewalle (1997)
  31. Wakelin MW, Sanz MJ, Dewar A et al. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 1996; 184: 229–39. (10.1084/jem.184.1.229) / J Exp Med by MW Wakelin (1996)
  32. Thompson RD, Wakelin MW, Larbi KY et al. Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo. J Immunol 2000; 165: 426–34. (10.4049/jimmunol.165.1.426) / J Immunol by RD Thompson (2000)
  33. Gude RP, Binda MM, Presas HL et al. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. J Biomed Sci 1999; 6: 133–41. (10.1007/BF02256444) / J Biomed Sci by RP Gude (1999)
  34. Navarro P, Ruco L, Dejana E. Differential Localization of VE-and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol 1998; 140: 1475–84 (10.1083/jcb.140.6.1475) / J Cell Biol by P Navarro (1998)
Dates
Type When
Created 22 years, 8 months ago (Dec. 23, 2002, 1:26 a.m.)
Deposited 1 month, 1 week ago (July 12, 2025, 6 p.m.)
Indexed 1 month, 1 week ago (July 12, 2025, 6:40 p.m.)
Issued 24 years, 10 months ago (Oct. 1, 2000)
Published 24 years, 10 months ago (Oct. 1, 2000)
Published Print 24 years, 10 months ago (Oct. 1, 2000)
Funders 0

None

@article{Voura_2000, title={Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells}, volume={18}, ISSN={1573-7276}, url={http://dx.doi.org/10.1023/a:1011884807746}, DOI={10.1023/a:1011884807746}, number={6}, journal={Clinical &amp; Experimental Metastasis}, publisher={Springer Science and Business Media LLC}, author={Voura, Evelyn B. and Chen, Ning and Siu, Chi-Hung}, year={2000}, month=oct, pages={527–532} }